| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 31.756 | 37.606 | 41.627 | 53.255 | 82.494 | 89.286 | 65.577 | 79.915 | 95.800 | 84.487 |
| Total Income - EUR | 40.971 | 53.421 | 44.816 | 58.030 | 82.494 | 94.454 | 70.429 | 79.915 | 95.942 | 84.546 |
| Total Expenses - EUR | 37.520 | 42.416 | 44.281 | 54.406 | 73.479 | 108.536 | 63.279 | 76.573 | 89.817 | 70.851 |
| Gross Profit/Loss - EUR | 3.451 | 11.005 | 535 | 3.624 | 9.015 | -14.082 | 7.150 | 3.342 | 6.125 | 13.696 |
| Net Profit/Loss - EUR | 2.222 | 10.486 | 87 | 3.044 | 8.190 | -16.043 | 6.460 | 2.663 | 5.165 | 11.863 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
Check the financial reports for the company - Bios-Impex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 13.571 | 12.855 | 5.468 | 5.110 | 4.758 | 4.420 | 4.079 | 3.848 | 3.594 | 3.332 |
| Current Assets | 17.896 | 15.484 | 16.110 | 18.857 | 18.950 | 8.673 | 16.918 | 15.412 | 20.226 | 29.839 |
| Inventories | 16.311 | 14.444 | 15.789 | 18.362 | 16.639 | 8.499 | 16.432 | 14.306 | 14.435 | 0 |
| Receivables | 1.260 | 169 | 167 | 188 | 160 | 0 | 147 | 0 | 176 | 15.713 |
| Cash | 326 | 871 | 154 | 307 | 2.151 | 174 | 339 | 1.107 | 5.614 | 14.125 |
| Shareholders Funds | 7.992 | 18.410 | 12.189 | 15.009 | 22.908 | 6.431 | 12.748 | 15.450 | 20.568 | 32.317 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 23.476 | 9.929 | 9.389 | 8.958 | 800 | 6.662 | 8.249 | 3.810 | 3.251 | 854 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Bios-Impex Srl